Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Impact of the COVID-19 pandemic on breast surgery and breast reconstruction in a Japanese university hospital setting

  • Shibata, Dai (Department of Plastic and Reconstructive Surgery, Tokyo Medical University) ;
  • Kawate, Takahiko (Department of Breast Surgery, Tokyo Medical University) ;
  • Komiya, Takako (Department of Plastic and Reconstructive Surgery, Tokyo Medical University) ;
  • Nakamura, Itaru (Department of Infectious Disease Medicine, Tokyo Medical University Hospital) ;
  • Ishikawa, Takashi (Department of Breast Surgery, Tokyo Medical University) ;
  • Matsumura, Hajime (Department of Plastic and Reconstructive Surgery, Tokyo Medical University)
  • Received : 2021.06.19
  • Accepted : 2021.09.30
  • Published : 2022.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. American College of Surgeons. COVID-19 guidelines for triage of breast cancer patients [Internet]. Chicago, IL: American College of Surgeons; c2020 [cited 2020 Sep 21]. Available from: https://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancer.
  2. American Society of Plastic Surgeons. Statement on breast reconstruction in the face of COVID-19 pandemic [Internet]. Arlington Heights, IL: American Society of Plastic Surgeons; c2020 [cited 2020 Sep 21]. Available from: https://www.plasticsurgery.org/documents/medicalprofessionals/COVID19-Breast-Reconstruction-Statement.pdf.
  3. Specht M, Sobti N, Rosado N, et al. High-efficiency same-day approach to breast reconstruction during the COVID-19 crisis. Breast Cancer Res Treat 2020;182:679-88. https://doi.org/10.1007/s10549-020-05739-7
  4. Lisa A, Battistini A, Giannasi S, et al. Breast reconstruction in a coronavirus disease 2019 hub. Plast Reconstr Surg Glob Open 2020;8:e3043. https://doi.org/10.1097/GOX.0000000000003043
  5. MacInnes EG, Piper J, Tait C, et al. Breast cancer surgery during the COVID-19 pandemic peak in the UK: operative outcomes. Cureus 2020;12:e9280.
  6. Obeng-Gyasi S, Oppong B, Paskett ED, et al. Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare? Breast Cancer Res Treat 2020;182:527-30. https://doi.org/10.1007/s10549-020-05740-0
  7. Belkacemi Y, Grellier N, Ghith S, et al. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low-and middle-income countries. Eur J Cancer 2020;135:130-46. https://doi.org/10.1016/j.ejca.2020.05.015
  8. Anwar SL, Harahap WA, Aryandono T. Perspectives on how to navigate cancer surgery in the breast, head and neck, skin, and soft tissue tumor in limited-resource countries during COVID-19 pandemic. Int J Surg 2020;79:206-12. https://doi.org/10.1016/j.ijsu.2020.05.072
  9. Gradishar WJ, Anderson BO, Abraham J, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2020;18:452-78. https://doi.org/10.6004/jnccn.2020.0016
  10. Spring LM, Gupta A, Reynolds KL, et al. Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis. JAMA Oncol 2016;2:1477-86. https://doi.org/10.1001/jamaoncol.2016.1897
  11. Alba E, Calvo L, Albanell J, et al. Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study. Ann Oncol 2012;23:3069-74. https://doi.org/10.1093/annonc/mds132
  12. Semiglazov VF, Semiglazov VV, Dashyan GA, et al. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer. Cancer 2007;110:244-54. https://doi.org/10.1002/cncr.22789
  13. Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol 2001;12:1527-32. https://doi.org/10.1023/A:1013128213451
  14. Lee J, Jung JH, Kim WW, et al. Patterns of delaying surgery for breast cancer during the COVID-19 outbreak in Daegu, South Korea. Front Surg 2020;7:576196. https://doi.org/10.3389/fsurg.2020.576196
  15. Chetta MD, Schoenbrunner AR, Lee CN. Postmastectomy breast reconstruction in the time of the novel coronavirus disease 2019 (COVID-19) pandemic. Plast Reconstr Surg Glob Open 2020;8:e2967. https://doi.org/10.1097/GOX.0000000000002967
  16. Al-Hilli Z, Thomsen KM, Habermann EB, et al. Reoperation for complications after lumpectomy and mastectomy for breast cancer from the 2012 National Surgical Quality Improvement Program (ACSNSQIP). Ann Surg Oncol 2015;22 Suppl 3:S459-69.
  17. Cavalcante FP, Novita GG, Millen EC, et al. Management of early breast cancer during the COVID-19 pandemic in Brazil. Breast Cancer Res Treat 2020;184:637-47. https://doi.org/10.1007/s10549-020-05877-y
  18. Vanni G, Pellicciaro M, Materazzo M, et al. Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency. Breast Cancer 2021;28:137-44. https://doi.org/10.1007/s12282-020-01137-5
  19. Ahmed M. Optimizing breast cancer surgery during the COVID-19 pandemic. Breast Cancer 2020;27:1045-7. https://doi.org/10.1007/s12282-020-01160-6